# Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.

> **NCT02244073** · NA · TERMINATED · sponsor: **Hospices Civils de Lyon** · enrollment: 2069 (actual)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** Human insulin - Insulin administration to control blood glucose level.

## Key facts

- **NCT ID:** NCT02244073
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-05
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 2069 (ACTUAL)
- **Why stopped:** Data safety monitoring board decision
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02244073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02244073, "Individualized Blood Glucose Control in ICU. The CONTROLING Study. A Double Blinded Multicentric Randomized Study.". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT02244073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*